Antirespiratory Virus Agents

This chapter reviews antiviral agents that have been, or are being, developed to treat or prevent respiratory viral infections. Detailed information is provided for approved agents and those in more advanced stages of clinical development. Agents in Phase I human studies or promising approaches that are still in preclinical development are described briefly. The reader is referred to the respective pathogen-specific chapters for full discussions of the viral agents and the diseases they cause.